Advertisement
Singapore markets close in 6 hours 13 minutes
  • Straits Times Index

    3,293.72
    +21.00 (+0.64%)
     
  • Nikkei

    38,333.97
    +781.81 (+2.08%)
     
  • Hang Seng

    17,099.33
    +270.40 (+1.61%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,641.00
    -207.66 (-0.31%)
     
  • CMC Crypto 200

    1,433.00
    +18.24 (+1.29%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,330.20
    -11.90 (-0.51%)
     
  • Crude Oil

    83.28
    -0.08 (-0.10%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,567.28
    +5.64 (+0.36%)
     
  • Jakarta Composite Index

    7,168.78
    +57.96 (+0.82%)
     
  • PSE Index

    6,571.25
    +64.45 (+0.99%)
     

Spinraza Has Emerged as Key Growth Driver for Ionis in 2017

In 1H17, Ionis Pharmaceuticals (IONS) recorded revenues of about $27.6 million related to royalty income received from Biogen from Spinraza sales.